ArticleFrontiers in oncology2022

Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy.

Juan A Marín-Jiménez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.